Impact of difficult-to-treat depression for patients and society: a real-world study
Despite the high economic burden, important needs remain unmet for DTD, especially for patients showing suicide risk with a first contact through the emergency setting. Earlier detection, innovative treatments, improved access to healthcare, and integration in mobile health programs should mitigate these gaps and improve clinical outcomes in this vulnerable population.
Authors
- Pablo Carrasco Arteaga
- Sonia Betzabeth Ticona Benavente (ORCID: https://orcid.org/0000-0002-6922-6732)
- Ismaël Conejero (ORCID: https://orcid.org/0000-0002-9142-1278)
- Enrique Baca‐García (ORCID: https://orcid.org/0000-0002-6963-6555)
- Alba Parra (ORCID: https://orcid.org/0000-0002-8191-6699)
- Jorge Lopez-Castroman
- Tania López
- Pablo Alonso-Torres
Institutions
- Centre National de la Recherche Scientifique (FR)
- Johnson & Johnson (United States) (US)
- Inserm (FR)
- Universidade de Santiago de Compostela (ES)
- Catholic University of the Maule (CL)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Hospital Universitario Rey Juan Carlos (ES)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Hospital General Universitario De Valencia (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Institut de Génomique Fonctionnelle (FR)
- Johnson & Johnson (Brazil) (BR)
- Hospital Universitario Infanta Leonor (ES)
- Universidad Autónoma de Madrid (ES)
- Université de Nîmes (FR)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-12-09
- DOI
- https://doi.org/10.3389/fpsyt.2025.1702137
- Primary Topic
- Suicide and Self-Harm Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00